Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
Brain and Nerve = Shinkei Kenkyu No Shinpo|March 23, 2016
[Molecular Genetics as Best Evidence in Glioma Diagnostics]Kenta Masui, Takashi KomoriNo Shinkei Geka. Neurological Surgery|June 7, 2021
[Molecular Diagnostic Approaches for Diffuse Gliomas Based on Updated WHO Classification and cIMPACT-NOW Proposals]Kenta Masui, Takashi KomoriPathology International|September 27, 2023
Metabolic and epigenetic reprogramming in the pathogenesis of glioblastoma: Toward the establishment of "metabolism-based pathology"Kenta Masui, Paul S MischelInternational Journal of Clinical Oncology|May 30, 2020
Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous SystemHiromi Onizuka, Kenta Masui, Takashi KomoriHandbook of Clinical Neurology|March 8, 2016
Molecular classification of gliomasKenta Masui, Paul S Mischel, Guido ReifenbergerBrain Tumor Pathology|June 14, 2016
Cancer metabolism as a central driving force of glioma pathogenesisKenta Masui, Webster K Cavenee, Paul S MischelNeuropathology : Official Journal of the Japanese Society of Neuropathology|May 28, 2011
Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical courseKenta Masui, Yukako Nakata, Naoki Fujii, et al.Brain Pathology (Zurich, Switzerland)|November 4, 2015
mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and EnvironmentKenta Masui, Webster K Cavenee, Paul S MischelWorld Neurosurgery|April 16, 2023
Clinical Features of Pituitary or Parasellar Tumor Onset with Cranial Nerve Palsy: Surgical Intervention ConsiderationsYuichi Oda, Kosaku Amano, Kenta Masui, et al.Trends in Endocrinology and Metabolism: TEM|May 27, 2014
mTORC2 in the center of cancer metabolic reprogrammingKenta Masui, Webster K Cavenee, Paul S MischelPageof 9